EFTR - eFFECTOR Therapeutics, Inc.
Previous close
0.1891
-11.761 -6,219.408%
Share volume: 0
Last Updated: Tue 02 Jul 2024 08:03:49 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$11.95
-11.76
-98.42%
Summary score
25%
Profitability
18%
Dept financing
25%
Liquidity
34%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-35.84%
Return on assets
-28.32%
Return on sales
-917.07%
Return on invested capital
1.94%
Total debt ratio
84.43%
Debt ratio change over timeo
0.96%
Current Ratio
3.63%
Quick Ratio
3.63%
Cash Position Ratio
3.43%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-36.27%
Return on assets
-35.42%
Return on sales
-1292.3%
Return on invested capital
37.71%
Total debt ratio
104.66%
Debt ratio change over timeo
1.78%
Current Ratio
0.95%
Quick Ratio
0.95%
Cash Position Ratio
0.89%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
209.35%
Return on assets
-38.96%
Return on sales
0%
Return on invested capital
36.56%
Total debt ratio
119.67%
Debt ratio change over time
2.27%
Current Ratio
0.82%
Quick Ratio
0.82%
Cash Position Ratio
0.75%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-158.2%
Return on assets
-164.48%
Return on sales
-1371.95%
Return on invested capital
-130.95%
Total debt ratio
96.22%
Debt ratio change over time
0.96%
Current Ratio
9.49%
Quick Ratio
9.49%
Cash Position Ratio
8.93%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EFTR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -35.84% | 7.58% | 36.15% | 7.75% |
| Return on assets | -28.32% | 2.95% | 3.44% | 5.85% |
| Return on sales | -917.07% | 30.63% | 35.3% | 41.32% |
| Return on invested capital | 1.94% | 3.7% | 6.05% | 20.44% |
| Profitability | 2% | 41% | 68% | 80% |
| Total debt ratio | 84.43% | 92.36% | 89.3% | 27.07% |
| Debt ratio change over time | 0.96% | 292.67% | 15.45% | 1.02% |
| Dept financing | 23% | 50% | 25% | 7% |
| Current Ratio | 0.95% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 0.95% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 0.89% | 0.3% | 1.72% | 2.75% |
| Liquididy | 71% | 18% | 29% | 63% |
| Short-term ratios | EFTR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -36.27% | 11.57% | 35.05% | 4.21% |
| Return on assets | -35.42% | 2.86% | 2.7% | 3.6% |
| Return on sales | -1292.3% | 27.99% | 31.88% | 33.53% |
| Return on invested capital | 37.71% | 2.16% | 6.93% | 9.79% |
| Profitability | 25% | 50% | 72% | 59% |
| Total debt ratio | 104.66% | 89.83% | 93.1% | 22.12% |
| Debt ratio change over time | 1.78% | 102.83% | 13.09% | 1.3% |
| Dept financing | 25% | 46% | 25% | 6% |
| Current Ratio | 0.95% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 0.95% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 0.89% | 0.3% | 1.72% | 2.75% |
| Liquididy | 18% | 12% | 40% | 75% |